UNTHSC and Bios Partners Startup Series – ZS Pharma

 

Join us on Thursday, May 9, 2019, for the next Startup Series event, hosted by Bios Partners and UNTHSC that will highlight and educate our community on the importance of entrepreneurship in Fort Worth. This edition will feature the co-founders of ZS Pharma, Al Guillem and Jeff Keyser, who will tell us their story about how they built their pharmaceutical company that they sold to AstraZeneca for $2.7 billion in 2015.

REGISTER

Dr. Ruthanne Thompson, Director – Science Education Research Laboratory, UNT-Denton: “The Science of Education” 12 pm, Friday, May 10 (RES 326)

 

The UNTHSC Center for Anatomical Sciences will host Ruthanne ‘Rudi’ Thompson, Ph.D., University Distinguished Teaching Professor of Biology and Director of the Science Education Research Laboratory, UNT Denton, for a seminar entitled “The Science of Education” at noon on Friday, May 10 in RES 326. Refreshments will be provided.

Dr. Thompson’s research interests include science teacher professional development and science education as a field of study. Dr. Thompson also serves as the Executive Director of the UNT Center for Learning Experimentation, Application, and Research (CLEAR) and Co-director of Teach North Texas (TNT).

UNTHSC Toastmasters – EAD291

 

Does speaking up in meetings give you anxiety? Does the thought of presenting to your class cause you to run for cover? Then now is the perfect time to take control of your anxiety, and check out the UNTHSC Toastmasters Club!

Join us every Tuesday from 12:05 – 12:55 PM, and check out how we can help you overcome your fear of public speaking. This week we will be in EAD 291.

Monique Gary Do, MSc, FACS

 

DR. MONIQUE GARY
Medical Director of the Grand View Health/
Penn Medicine Network Cancer Program

Monique Gary DO, MSc, FACS is a board certified, fellowship-trained Breast Surgical Oncologist and Medical Director of the Grand View Health/Penn Medicine Network Cancer Program in Sellersville, PA. In addition, she has also served as the Director of the Breast Program since its accreditation in 2015. She is the founder of the Cancer Genetic Risk and Prevention Program at GVH, which provides genetic counseling and high risk management for patients with strong family history of malignancy and those with known hereditary cancer syndromes.

A native of Philadelphia, PA, Dr. Gary completed undergraduate studies at Florida A&M University and began as a researcher and community outreach liaison with the Fox Chase Cancer Center, where she helped establish the free mobile mammography and breast screening program and was a two-time recipient of the AACR Minority Scholar Award in Cancer Research. Dr. Gary obtained a Master’s degree in molecular biology, followed by the Doctorate in Osteopathic Medicine from the Philadelphia College of Osteopathic Medicine. After completion of her general surgery training at University of Massachusetts- Berkshire Medical Center campus, she completed fellowship training in breast surgical oncology at Georgetown University Hospital in Washington, DC.

Dr. Gary specializes in benign and malignant breast disease, high risk genetics, state of the art, minimally-invasive breast surgery approaches, as well as cancer nutrition and prevention. She is passionate about research and chairs the Institutional Review Board, ad is a principal investigator for institutional community clinical trials. She is committed to medical education and holds faculty appointments as a Clinical Associate Professor of Surgery with the University of Pennsylvania, PCOM and University of New England College of Osteopathic Medicine (UNECOM). Dr. Gary has served as a guest editor for BAOJ Surgery and the Medical Science Educator, and is the author of several peer-reviewed publications in cancer progression, surgical outcomes and disparities research. She is passionate about using her expertise to develop programs to address cancer risk/prevention and health equity for marginalized and underserved populations including ethnic, racial, LGBTQ+, religious and other minority groups. Dr. Gary is an invited speaker and collaborator with Susan G. Komen and Living Beyond Breast Cancer (LBBC), remains actively engaged in surgical societies, and is currently serving a three-year term as chair of the Young Surgeons Committee of the American Society of Breast Surgeons. She has been recognized as a Top Breast Surgeon in Pennsylvania for 2017 and 2018 and is a diplomate and Fellow of the American College of Surgeons.

Learning Objectives:
“Lesson from the Field: The Progress and the Promise of Eliminating Breast Cancer Disparities”

Breast cancer is a complex disease with molecular mechanisms which remain poorly elucidated in certain populations. An in depth understanding of the natural history and evolution of cancer disparities among women with breast cancer is essential for competency in screening, diagnosis, treatment and prevention, particularly in the African American community.

In addition to the historical overview, this session will engage participants to:

– Critically evaluate the data and policies surrounding health equity in breast cancer, particularly in special populations inclusive of but not limited to African Americans and other underrepresented groups
– Discuss the social determinants of health and cancer in these populations
– Evaluate current screening guidelines and their applicability to those populations from the perspective of the at-risk group(s)
– develop strategies for community education, preventive initiatives and partnership by healthcare providers with an action plan for the community.

Healthy males age 58 to 84 needed for a research study.

 

The Department of Family Medicine/OMM is recruiting healthy men for a study entitled “Effects of OMT on Gait Kinematics and Postural Control in Parkinson Disease”.

The purpose of this study is to determine the effects of osteopathic manipulative treatment (OMT) on gait and balance for healthy adults and persons with Parkinson disease. Our long term goal is to create a protocol that improves gait and postural control, and helps to reduce falls in persons with PD. You are invited to participate as a control subject and your participation involves one visit which may last up to 5 hours. We are currently need healthy males between 58 to 84 years old. During the visit you will be asked to perform balance tasks and may receive OMT. All testing is non-invasive, and compensation will be provided.

If you are interested in participating in this study, please contact the Project Coordinator at 817-735-0246 or 817-735-2177.

The Fruits of 2018 Seed Grants: talks by Dr. Liu and Dr. Uteshev

 

The Office of Research Development & Commercialization invites you to attend “The Fruits of 2018 Seed Grants”, a series of talks, where seed grants awardees present the results of their projects.

The third seminar of the series features Dr. Jin Liu, and Dr. Victor Uteshev.
Dr. Jin Liu will present her project “Development of Allosteric Modulators to Enhance CRISPR-Cas9 Specificity” and
Dr. Victor Uteshev will present his project “Therapeutic efficacy of EPGN973 after ischemic brain injury in rats”.
Refreshments will be provided.

When: Thursday, May 9th at 10 AM.
Where: LIB-110.